PATENT CLAIM ANALYSIS

Application Number: 16090915
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "457000"]

Abstract:
The present invention relates to controlled release pharmaceutical formulations comprising an atypical antipsychotic agent such as Paliperidone in the form of capsule filled with mini-tablets that provide zero order drug release. It also relates to a process for the preparation thereof.

Claim (Index 4):
A controlled release formulation according to  claim 3 , wherein the at least one hydrophilic polymer is selected from the group consisting of xanthan gum, guar gum, carrageenan, dextran, polyacrylic acid, polyethylene glycol, polyvinylalcohol, polyvinylpyrrolidone, hydroxypropylmethylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose, and hydroxyethylcellulose.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 97.0
- Lexical Diversity: 1.13158
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13990861', '15912438', '14238961', '16029239', '16058769']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7401954738211258
- 35 USC 102 Novelty (BERT): 0.4749283655355842
- Combined Prediction Score: 0.7136687629925716
- Mean Citation Score: 164.92661200000003
- Max Citation Score: 166.32453999999996
- Similarity Product: 120.8239483296692

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test